New ASTRO letter to CMS outlines pathways to achieve value-based payment for radiation oncology

The American Society for Radiation Oncology delivered comments to CMS following a proposed indefinite delay for the radiation oncology APM. Recommendations outline actionable steps to stabilize Medicare reimbursement, prioritize health equity, reduce unnecessary administrative burden and improve cancer outcomes.

Increased access to care and reduced treatment delays lead priorities as radiation oncologists meet with members of Congress

Radiation oncologists will meet with congressional leaders and staff today to ask for their support of policies to bolster access and equity in cancer care. Today’s American Society for Radiation Oncology (ASTRO) Advocacy Day is the first to be held in-person since the start of the COVID-19 pandemic.

CMS 2022 final rules: ASTRO deeply concerned and disappointed, emphasizes need for legislative solution

The American Society for Radiation Oncology (ASTRO) issued the following statement today in response to the 2022 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules announced by the Centers for Medicare and Medicaid Services (CMS).

Senators and representatives unite to call on CMS to protect patient access to high-quality radiation treatments

Eighty-five members of Congress have joined together to issue bipartisan, bicameral oversight letters that call on CMS to scale back severe cuts to radiation therapy reimbursement. Without action from CMS, radiation oncology will face estimated cuts of $300 million starting January 1, 2022, jeopardizing patient access to care.

ASTRO submits comments to CMS: Stop the draconian cuts that will harm cancer patient care

The American Society for Radiation Oncology (ASTRO) submitted two comment letters to the Centers for Medicare and Medicaid Services (CMS) today urging the agency to reconsider policy changes that will result in $300 million in Medicare cuts for radiation therapy services starting January 1, 2022.